Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 286

1.

Health-related quality of life in inflammatory bowel disease in a Danish population-based inception cohort.

Christiansen LK, Lo B, Bendtsen F, Vind I, Vester-Andersen MK, Burisch J.

United European Gastroenterol J. 2019 Aug;7(7):942-954. doi: 10.1177/2050640619852532. Epub 2019 May 17.

2.

Acetaminophen toxicity induces mitochondrial complex I inhibition in human liver tissue.

Chrøis KM, Larsen S, Pedersen JS, Rygg MO, Boilsen AEB, Bendtsen F, Dela F.

Basic Clin Pharmacol Toxicol. 2019 Aug 12. doi: 10.1111/bcpt.13304. [Epub ahead of print]

PMID:
31403256
3.

Cardiac dysfunction in cirrhosis: a 2-yr longitudinal follow-up study using advanced cardiac imaging.

Wiese S, Hove JD, Mo S, Mygind ND, Tønnesen J, Petersen CL, Clemmesen JO, Goetze JP, Bendtsen F, Møller S.

Am J Physiol Gastrointest Liver Physiol. 2019 Sep 1;317(3):G253-G263. doi: 10.1152/ajpgi.00402.2018. Epub 2019 Jun 19.

PMID:
31216181
4.

Direct and Indirect Costs of Inflammatory Bowel Disease: Ten Years of Follow Up in a Danish Population-Based Inception Cohort.

Lo B, Vind I, Vester-Andersen MK, Bendtsen F, Burisch J.

J Crohns Colitis. 2019 May 10. pii: jjz096. doi: 10.1093/ecco-jcc/jjz096. [Epub ahead of print]

PMID:
31076743
5.

An update on cirrhotic cardiomyopathy.

Møller S, Danielsen KV, Wiese S, Hove JD, Bendtsen F.

Expert Rev Gastroenterol Hepatol. 2019 May;13(5):497-505. doi: 10.1080/17474124.2019.1587293. Epub 2019 Mar 8.

PMID:
30802157
6.

[Magnetic resonance imaging for the diagnosis of non-alcoholic fatty liver disease].

Kirkegaard-Klitbo DM, Danielsen KV, Hanson LG, Gluud LL, Siebner HR, Bendtsen F, Benfield T.

Ugeskr Laeger. 2019 Feb 25;181(9). pii: V11180792. Danish.

PMID:
30799812
7.

Enhanced processing of von Willebrand factor reflects disease severity and discriminates severe portal hypertension in cirrhosis.

Langholm LL, Manon-Jensen T, Karsdal MA, Bendtsen F, Leeming DJ, Møller S.

Eur J Gastroenterol Hepatol. 2019 Aug;31(8):1040-1048. doi: 10.1097/MEG.0000000000001380.

PMID:
30768435
8.

Collagen type IV remodelling gender-specifically predicts mortality in decompensated cirrhosis.

Lehmann J, Praktiknjo M, Nielsen MJ, Schierwagen R, Meyer C, Thomas D, Violi F, Strassburg CP, Bendtsen F, Møller S, Krag A, Karsdal MA, Leeming DJ, Trebicka J.

Liver Int. 2019 May;39(5):885-893. doi: 10.1111/liv.14070. Epub 2019 Mar 7.

9.

A 10-Year Follow-up Study of the Natural History of Perianal Crohn's Disease in a Danish Population-Based Inception Cohort.

Zhao M, Lo BZS, Vester-Andersen MK, Vind I, Bendtsen F, Burisch J.

Inflamm Bowel Dis. 2019 Jun 18;25(7):1227-1236. doi: 10.1093/ibd/izy374.

PMID:
30576474
10.

Carvedilol versus traditional, non-selective beta-blockers for adults with cirrhosis and gastroesophageal varices.

Zacharias AP, Jeyaraj R, Hobolth L, Bendtsen F, Gluud LL, Morgan MY.

Cochrane Database Syst Rev. 2018 Oct 29;10:CD011510. doi: 10.1002/14651858.CD011510.pub2. Review.

PMID:
30372514
11.

Indocyanine green retention test in cirrhosis and portal hypertension: Accuracy and relation to severity of disease.

Møller S, la Cour Sibbesen E, Madsen JL, Bendtsen F.

J Gastroenterol Hepatol. 2019 Jun;34(6):1093-1099. doi: 10.1111/jgh.14470. Epub 2018 Oct 4.

PMID:
30221390
12.

No effect of rifaximin on soluble CD163, mannose receptor or type III and IV neoepitope collagen markers in decompensated cirrhosis: Results from a randomized, placebo controlled trial.

Kimer N, Gudmann NS, Pedersen JS, Møller S, Nielsen MJ, Leeming DJ, Karsdal MA, Møller HJ, Bendtsen F, Grønbæk H.

PLoS One. 2018 Sep 5;13(9):e0203200. doi: 10.1371/journal.pone.0203200. eCollection 2018.

13.

Myocardial extracellular volume quantified by magnetic resonance is increased in cirrhosis and related to poor outcome.

Wiese S, Hove J, Mo S, Mookerjee RP, Petersen CL, Vester-Andersen MK, Mygind ND, Goetze JP, Kjaer A, Bendtsen F, Møller S.

Liver Int. 2018 Sep;38(9):1614-1623. doi: 10.1111/liv.13870. Epub 2018 May 21.

PMID:
29714035
14.

Pronounced Coronary Arteriosclerosis in Cirrhosis: Influence on Cardiac Function and Survival?

Danielsen KV, Wiese S, Hove J, Bendtsen F, Møller S.

Dig Dis Sci. 2018 May;63(5):1355-1362. doi: 10.1007/s10620-018-5006-7. Epub 2018 Mar 8.

PMID:
29516327
15.

Changes in Disease Behaviour and Location in Patients With Crohn's Disease After Seven Years of Follow-Up: A Danish Population-based Inception Cohort.

Lo B, Vester-Andersen MK, Vind I, Prosberg M, Dubinsky M, Siegel CA, Bendtsen F, Burisch J.

J Crohns Colitis. 2018 Feb 28;12(3):265-272. doi: 10.1093/ecco-jcc/jjx138.

PMID:
29506105
16.

Hepatic and cardiac hemodynamics and systemic inflammation in cirrhosis: It takes three to tango.

Coenraad MJ, Porcher R, Bendtsen F.

J Hepatol. 2018 May;68(5):887-889. doi: 10.1016/j.jhep.2018.02.007. Epub 2018 Feb 17. No abstract available.

PMID:
29462644
17.

Acute decompensation boosts hepatic collagen type III deposition and deteriorates experimental and human cirrhosis.

Praktiknjo M, Lehmann J, Nielsen MJ, Schierwagen R, Uschner FE, Meyer C, Thomas D, Strassburg CP, Bendtsen F, Møller S, Krag A, Karsdal MA, Leeming DJ, Trebicka J.

Hepatol Commun. 2018 Jan 18;2(2):211-222. doi: 10.1002/hep4.1135. eCollection 2018 Feb.

18.

The relationship between the use of statins and mortality, severity, and pancreatic cancer in Danish patients with chronic pancreatitis.

Bang UC, Watanabe T, Bendtsen F.

Eur J Gastroenterol Hepatol. 2018 Mar;30(3):346-351. doi: 10.1097/MEG.0000000000001060.

PMID:
29309396
19.

Total bile acid levels are associated with left atrial volume and cardiac output in patients with cirrhosis.

Voiosu AM, Wiese S, Voiosu TA, Hove J, Bendtsen F, Møller S.

Eur J Gastroenterol Hepatol. 2018 Apr;30(4):392-397. doi: 10.1097/MEG.0000000000001043.

PMID:
29227330
20.

Low ascitic fluid total protein levels is not associated to the development of spontaneous bacterial peritonitis in a cohort of 274 patients with cirrhosis.

Mo S, Bendtsen F, Wiese SS, Kimer N.

Scand J Gastroenterol. 2018 Feb;53(2):200-205. doi: 10.1080/00365521.2017.1411973. Epub 2017 Dec 7.

PMID:
29214880
21.

Letter: safety and efficacy of using statins in patients with cirrhosis-authors' reply.

Bang UC, Benfield T, Bendtsen F.

Aliment Pharmacol Ther. 2017 Dec;46(11-12):1125-1126. doi: 10.1111/apt.14364. No abstract available.

22.

Transjugular intrahepatic portosystemic shunt: impact on systemic hemodynamics and renal and cardiac function in patients with cirrhosis.

Busk TM, Bendtsen F, Poulsen JH, Clemmesen JO, Larsen FS, Goetze JP, Iversen JS, Jensen MT, Møgelvang R, Pedersen EB, Bech JN, Møller S.

Am J Physiol Gastrointest Liver Physiol. 2018 Feb 1;314(2):G275-G286. doi: 10.1152/ajpgi.00094.2017. Epub 2017 Oct 26.

23.

Editorial: the role of statins in the treatment of alcohol-related cirrhosis - Authors' reply.

Bang UC, Benfield T, Bendtsen F.

Aliment Pharmacol Ther. 2017 Nov;46(9):893-894. doi: 10.1111/apt.14281. No abstract available.

24.

Anti-NKG2D mAb: A New Treatment for Crohn's Disease?

Vadstrup K, Bendtsen F.

Int J Mol Sci. 2017 Sep 16;18(9). pii: E1997. doi: 10.3390/ijms18091997. Review.

25.

The pathophysiology of arterial vasodilatation and hyperdynamic circulation in cirrhosis.

Møller S, Bendtsen F.

Liver Int. 2018 Apr;38(4):570-580. doi: 10.1111/liv.13589. Epub 2018 Jan 15. Review.

PMID:
28921803
26.

Reduced risk of decompensation and death associated with use of statins in patients with alcoholic cirrhosis. A nationwide case-cohort study.

Bang UC, Benfield T, Bendtsen F.

Aliment Pharmacol Ther. 2017 Oct;46(7):673-680. doi: 10.1111/apt.14243.

27.

Effects of transjugular intrahepatic portosystemic shunt (TIPS) on blood volume distribution in patients with cirrhosis.

Busk TM, Bendtsen F, Henriksen JH, Fuglsang S, Clemmesen JO, Larsen FS, Møller S.

Dig Liver Dis. 2017 Dec;49(12):1353-1359. doi: 10.1016/j.dld.2017.06.011. Epub 2017 Jun 27.

PMID:
28729141
28.

The royal free hospital cirrhosis glomerular filtration rate: Validation in a danish cohort.

Pedersen JS, Kimer N, Henriksen JH, Bendtsen F, Møller S.

Hepatology. 2017 Oct;66(4):1360-1361. doi: 10.1002/hep.29386. Epub 2017 Aug 26. No abstract available.

PMID:
28727168
29.

NKG2D ligand expression in Crohn's disease and NKG2D-dependent stimulation of CD8+ T cell migration.

Vadstrup K, Galsgaard ED, Jensen H, Lanier LL, Ryan JC, Chen SY, Nolan GP, Vester-Andersen MK, Pedersen JS, Gerwien J, Jensen T, Bendtsen F.

Exp Mol Pathol. 2017 Aug;103(1):56-70. doi: 10.1016/j.yexmp.2017.06.010. Epub 2017 Jul 3.

30.

Rifaximin has minor effects on bacterial composition, inflammation, and bacterial translocation in cirrhosis: A randomized trial.

Kimer N, Pedersen JS, Tavenier J, Christensen JE, Busk TM, Hobolth L, Krag A, Al-Soud WA, Mortensen MS, Sørensen SJ, Møller S, Bendtsen F; members of the CoRif study group.

J Gastroenterol Hepatol. 2018 Jan;33(1):307-314. doi: 10.1111/jgh.13852.

PMID:
28671712
31.

Plasma cystatin C is a predictor of renal dysfunction, acute-on-chronic liver failure, and mortality in patients with acutely decompensated liver cirrhosis.

Markwardt D, Holdt L, Steib C, Benesic A, Bendtsen F, Bernardi M, Moreau R, Teupser D, Wendon J, Nevens F, Trebicka J, Garcia E, Pavesi M, Arroyo V, Gerbes AL.

Hepatology. 2017 Oct;66(4):1232-1241. doi: 10.1002/hep.29290. Epub 2017 Aug 26.

PMID:
28545169
32.

Proximal Disease Extension in Patients With Limited Ulcerative Colitis: A Danish Population-based Inception Cohort.

Burisch J, Ungaro R, Vind I, Prosberg MV, Bendtsen F, Colombel JF, Vester-Andersen MK.

J Crohns Colitis. 2017 Oct 1;11(10):1200-1204. doi: 10.1093/ecco-jcc/jjx066.

33.

Bile acids and cardiovascular function in cirrhosis.

Voiosu A, Wiese S, Voiosu T, Bendtsen F, Møller S.

Liver Int. 2017 Oct;37(10):1420-1430. doi: 10.1111/liv.13394. Epub 2017 Mar 13. Review.

PMID:
28222247
34.

Aquaporin-2 excretion in hospitalized patients with cirrhosis: Relation to development of renal insufficiency and mortality.

Busk TM, Møller S, Pedersen EB, Gerbes A, Krag A, Peck-Radosavljevic M, Frankova S, Coenraad MJ, Bendtsen F.

J Gastroenterol Hepatol. 2017 May;32(5):1087-1093. doi: 10.1111/jgh.13641.

PMID:
28092112
35.

Rifaximin has no effect on hemodynamics in decompensated cirrhosis: A randomized, double-blind, placebo-controlled trial.

Kimer N, Pedersen JS, Busk TM, Gluud LL, Hobolth L, Krag A, Møller S, Bendtsen F; Copenhagen Rifaximin (CoRif) Study Group.

Hepatology. 2017 Feb;65(2):592-603. doi: 10.1002/hep.28898. Epub 2016 Dec 24.

PMID:
27775818
36.

The soluble mannose receptor is released from the liver in cirrhotic patients, but is not associated with bacterial translocation.

Laursen TL, Rødgaard-Hansen S, Møller HJ, Mortensen C, Karlsen S, Nielsen DT, Frevert S, Clemmesen JO, Møller S, Jensen JS, Bendtsen F, Grønbaek H.

Liver Int. 2017 Apr;37(4):569-575. doi: 10.1111/liv.13262. Epub 2016 Oct 21.

PMID:
27706896
37.

[Old wine in new bottles: Lactulose works in hepatic encephalopathy].

Bendtsen F.

Ugeskr Laeger. 2016 Oct 17;178(42). pii: V68568. Danish. No abstract available.

PMID:
27745574
38.

The association between the gut microbiota and the inflammatory bowel disease activity: a systematic review and meta-analysis.

Prosberg M, Bendtsen F, Vind I, Petersen AM, Gluud LL.

Scand J Gastroenterol. 2016 Dec;51(12):1407-1415. Epub 2016 Aug 9. Review.

PMID:
27687331
39.

Neutrophil gelatinase-associated lipocalin and cystatin C in cirrhosis and portal hypertension: Relations to organ extraction and dysfunction.

Hurry PK, Poulsen JH, Bendtsen F, Møller S.

J Gastroenterol Hepatol. 2017 Feb;32(2):473-481. doi: 10.1111/jgh.13492.

PMID:
27435243
40.

Presence of alcoholic steatohepatitis, but no selective histological feature, indicates an increased risk of cirrhosis and premature death.

Semb S, Neermark S, Dam-Larsen S, Franzmann MB, Albrectsen J, Kallemose T, Becker U, Bendtsen F.

Scand J Gastroenterol. 2016 Nov;51(11):1367-74. doi: 10.1080/00365521.2016.1203016. Epub 2016 Jul 5.

PMID:
27381376
41.

Hepatorenal syndrome in cirrhosis: diagnostic, pathophysiological, and therapeutic aspects.

Busk TM, Bendtsen F, Møller S.

Expert Rev Gastroenterol Hepatol. 2016 Oct;10(10):1153-1161. doi: 10.1080/17474124.2016.1196132. Epub 2016 Jun 16.

PMID:
27248461
42.

Indocyanine green retention test (ICG-r15) as a noninvasive predictor of portal hypertension in patients with different severity of cirrhosis.

Pind ML, Bendtsen F, Kallemose T, Møller S.

Eur J Gastroenterol Hepatol. 2016 Aug;28(8):948-54. doi: 10.1097/MEG.0000000000000611.

PMID:
27172450
43.

Validation and Optimization of an Ex Vivo Assay of Intestinal Mucosal Biopsies in Crohn's Disease: Reflects Inflammation and Drug Effects.

Vadstrup K, Galsgaard ED, Gerwien J, Vester-Andersen MK, Pedersen JS, Rasmussen J, Neermark S, Kiszka-Kanowitz M, Jensen T, Bendtsen F.

PLoS One. 2016 May 12;11(5):e0155335. doi: 10.1371/journal.pone.0155335. eCollection 2016.

44.

The macrophage activation marker sCD163 combined with markers of the Enhanced Liver Fibrosis (ELF) score predicts clinically significant portal hypertension in patients with cirrhosis.

Sandahl TD, McGrail R, Møller HJ, Reverter E, Møller S, Turon F, Hernández-Gea V, Bendtsen F, Vilstrup H, Garcia-Pagan JC, Grønbaek H.

Aliment Pharmacol Ther. 2016 Jun;43(11):1222-31. doi: 10.1111/apt.13618. Epub 2016 Apr 7.

45.

Effect of propranolol on survival in patients with decompensated cirrhosis: a nationwide study based Danish patient registers.

Bang UC, Benfield T, Hyldstrup L, Jensen JE, Bendtsen F.

Liver Int. 2016 Sep;36(9):1304-12. doi: 10.1111/liv.13119. Epub 2016 Apr 4.

PMID:
26992041
46.

Advances in the treatment of portal hypertension in cirrhosis.

Kimer N, Wiese S, Mo S, Møller S, Bendtsen F.

Expert Rev Gastroenterol Hepatol. 2016 Aug;10(8):961-9. doi: 10.1586/17474124.2016.1166952. Epub 2016 Mar 28. Review.

PMID:
26982499
47.

Assessment of response to beta-blockers by expression of βArr2 and RhoA/ROCK2 in antrum mucosa in cirrhotic patients.

Trebicka J, von Heydebrand M, Lehmann J, Tofteng F, Busk T, Jensen HL, Rohde J, Reiberger T, Mortensen C, Schierwagen R, Klein S, Møller S, Bendtsen F, Krag A.

J Hepatol. 2016 Jun;64(6):1265-73. doi: 10.1016/j.jhep.2016.01.022. Epub 2016 Jan 28.

PMID:
26827791
48.

Long-term Compliance with Oral 5-aminosalicylic Acid Therapy and Risk of Disease Recurrence in Patients with Ulcerative Colitis: A Population-based Cohort Study.

Prosberg MV, Vester-Andersen MK, Andersson M, Jess T, Andersen JT, Vind I, Bendtsen F.

Inflamm Bowel Dis. 2016 Apr;22(4):925-32. doi: 10.1097/MIB.0000000000000700.

PMID:
26818426
49.

Effects of endogenous GLP-1 and GIP on glucose tolerance after Roux-en-Y gastric bypass surgery.

Svane MS, Bojsen-Møller KN, Nielsen S, Jørgensen NB, Dirksen C, Bendtsen F, Kristiansen VB, Hartmann B, Holst JJ, Madsbad S.

Am J Physiol Endocrinol Metab. 2016 Apr 1;310(7):E505-14. doi: 10.1152/ajpendo.00471.2015. Epub 2016 Jan 19.

50.

Plasma ADAMTS-13 protein is not associated with portal hypertension or hemodynamic changes in patients with cirrhosis.

Wiese S, Timm A, Nielsen LB, Goetze JP, Bendtsen F, Møller S.

Dig Liver Dis. 2016 Apr;48(4):404-8. doi: 10.1016/j.dld.2015.12.003. Epub 2015 Dec 17.

PMID:
26775093

Supplemental Content

Loading ...
Support Center